Immunosuppressive-drugs of this class suppress the body’s natural immune system by inhibiting an enzyme known as inosine monophosphate dehydrogenase (IMPDH). This enzyme is involved in the proliferation of lymphocytes.
This drug is used to prevent organ rejection following heart and kidney transplantation. Other uses include the treatment of lupus nephritis, systemic vasculitis, rheumatoid arthritis and psoriasis. Mycophenolate has many proposed mechanisms of action, including T and B lymphocyte depletion. After oral administration, mycophenolate is altered to its biologically active form, mycophenolic acid.
| Condition | Information | Oral Dosage | Intravenous Dosage |
Renal transplant rejection |
Used in combination with cyclosporine and corticosteroids |
1 g twice daily for mofetil |
1 g twice daily for mofetil |
Lupus nephritis, systemic vasculitis |
|
1 g twice daily for mofetil |
|
DO NOT take this medicine if you are allergic to mycophenolate mofetil/mycophenolic acid or if you are allergic to polysorbate 80, which is the IV formulation.
| Drug Name | Interaction |
Azathioprine (Imuran®) |
Azathioprine, similar to mycophenolate mofetil can decrease white blood cells, leading to a greater suppression potential |
Antacids |
Decrease absorption of mycophenolate mofetil |
Acyclovir (Zovirax®), Ganciclovir (Cytovene®) |
Increases blood levels of acyclovir, ganciclovir and mycophenolate mofetil |
Vaccines: |
Vaccines may be less effective or may have increased risk of infection from the live virus derived vaccine |